Lithium
Lithobid, Eskalith
Also known as: Tambocor
Class Ic antiarrhythmic: potent sodium-channel blockade widening QRS, on top of ibogaine's potassium-channel (hERG) blockade. Combined conduction impairment is proarrhythmic.
Severity
Contraindicated
Mechanism
Cardiac conduction (bradycardia / AV node)
Protocol Status
Generally not eligible until alternative management is established
Restart Delay
Physician discretion
What "Contraindicated" Means
Absolute prohibition without an enforced washout. Treatment cannot proceed safely until the medication has been cleared from the body for the protocol's required interval.
Clinical Action
Requires cardiology sign-off and an alternative rhythm strategy before treatment can be considered.
Where the Washout Happens
Generally not eligible until alternative management is established
Pharmacology (e.g., ultra-long half-life) makes safe washout impractical within any reasonable treatment window. Treatment generally cannot proceed until cardiology or the prescribing physician has established alternative management.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
Ibogaine slows the sinus node and AV conduction. Beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, and lithium can deepen bradycardia or generate higher-degree AV block. Heart-rate-slowing medications are typically held on dosing day with continuous telemetry monitoring.
Same Mechanism
Same Severity Tier
Serotonergic activity (serotonin syndrome)
Prozac, Sarafem
Serotonergic activity (serotonin syndrome)
Zoloft
Serotonergic activity (serotonin syndrome)
Paxil, Pexeva
QT-interval prolongation
Celexa
QT-interval prolongation
Lexapro
Serotonergic activity (serotonin syndrome)
Luvox
Common Questions
Contraindicated. Class Ic antiarrhythmic: potent sodium-channel blockade widening QRS, on top of ibogaine's potassium-channel (hERG) blockade. Combined conduction impairment is proarrhythmic. Requires cardiology sign-off and an alternative rhythm strategy before treatment can be considered.
Generally not eligible until alternative management is established. Pharmacology (e.g., ultra-long half-life) makes safe washout impractical within any reasonable treatment window. Treatment generally cannot proceed until cardiology or the prescribing physician has established alternative management.
Cardiac conduction (bradycardia / AV node). Ibogaine slows the sinus node and AV conduction. Beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, and lithium can deepen bradycardia or generate higher-degree AV block. Heart-rate-slowing medications are typically held on dosing day with continuous telemetry monitoring.
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Flecainide — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 112 medications in the A–Z directory.